For columnist Tanita Allen, humor often serves as a coping mechanism in life with Huntington's. But sometimes it's more harmful than helpful.| Huntington's Disease News
Early molecular changes in Huntington’s appear to be largely due to the loss of normal huntingtin protein function, a new study found.| Huntington's Disease News
Speakers at the 2025 HDSA convention highlighted clinical trials testing several treatments aimed at mutant huntingtin.| Huntington's Disease News
Several observational studies to help improve knowledge of Huntington's and speed treatment development are now enrolling patients in the U.S.| Huntington's Disease News
Early care planning helps Huntington's patients and families cope as the disease progresses, speakers at the HDSA annual convention said.| Huntington's Disease News
Participating in dance classes may help people with Huntington's disease improve their balance and maintain their functional capacity.| Huntington's Disease News
At the HDSA 2025 convention, social workers reported that building community among Huntington's patients can help combat disease stigma.| Huntington's Disease News
Columnist Tanita Allen focuses on the small wins and the proper mindset as part of making progress over the setbacks of Huntington's disease.| Huntington's Disease News
A genetic disease like Huntington's affects the entire family tree, not just those who inherit the condition, says columnist Carlos Briceño.| Huntington's Disease News
Strategies being explored as treatments for ALS might also be useful in the treatment of Huntington's disease, a study suggested.| Huntington's Disease News
Columnist Carlos Briceño says telehealth has made the process of seeking mental healthcare easier and more comfortable for his wife, Jill.| Huntington's Disease News
Columnist Carlos Briceño's wife, Jill, feared the weight loss that can come with Huntington's. She recently learned her fears were misplaced.| Huntington's Disease News
US neurologists are optimistic about the potential for a new Huntington's disease treatment - preferably a gene therapy - per a market survey.| Huntington's Disease News
Scientists uncovered a Huntington's disease mechanism leading to abnormal toxic protein production that was called "one piece of the puzzle."| Huntington's Disease News
Columnist Carlos Briceño sympathizes with his wife's stress as she handles the TSA PreCheck application process with her Huntington's.| Huntington's Disease News
After receiving an ADHD diagnosis, columnist Carlos Briceño's wife, Jill, carefully considers the best options for managing it.| Huntington's Disease News
Columnist Carlos Briceño finds an online resource to help Huntington's patients answer the question "What is chorea?"| Huntington's Disease News
Because depression often occurs with Huntington's, columnist Carlos Briceño shares his wife's story to remind others that they're not alone.| Huntington's Disease News
No description.| Huntington's Disease News
Margarida Maia is a science writer for Huntington's Disease News with a PhD in biomedical sciences. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Ingrezza's effects on Huntington's-associated chorea appear stronger over time, according to an analysis of the Phase 3 KINECT-HD trial.| Huntington's Disease News
Ingrezza has been associated with sustained reductions in Huntington's chorea, regardless of concurrent antipsychotic medication use.| Huntington's Disease News
The once-daily oral therapy Ingrezza, from Neurocrine, has now been approved in the U.S. to treat chorea in adults with Huntington’s disease.| Huntington's Disease News
Columnist Carlos Briceño and his wife delay talking about any HD symptoms they notice, lest they fall victim to the frequency illusion.| Huntington's Disease News
Society wants us to act heroic, but that's not always possible, opines columnist Carlos Briceño, who recommends embracing vulnerability.| Huntington's Disease News
Columnist Carlos Briceño shares how his wife, Jill, who has Huntington's, has developed new strategies to counter her increasing anxiety.| Huntington's Disease News
Steve Bryson is a science writer for Huntington's Disease News with a PhD in biochemistry. He covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Managing anxiety can be difficult, regardless of whether or not it's a symptom of Huntington's disease, says columnist Carlos Briceño.| Huntington's Disease News
The outlook for the Huntington's community has never been brighter, Louise Vetter, president and CEO of the HDSA, said at the organization's annual convention.| Huntington's Disease News
Columnist Carlos Briceño says it's not Huntington's that defines his wife, Jill, but rather her fighting spirit and fierce attitude.| Huntington's Disease News
Marisa Wexler is a senior science writer for Huntington's Disease News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Walking, aerobics, and strength training have been shown to help people with Huntington’s to stay active and maintain their mobility.| Huntington's Disease News
Marta Figueiredo is a science writer for Huntington's Disease News with a PhD in biomedical sciences. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Patricia Inacio is a science writer for Huntington's Disease News with a PhD in cell biology. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Two proteins, neurofilament light chain and phosphorylated tau, can serve as markers of Huntington's disease progression, a study found.| Huntington's Disease News
Mary Chapman is an award-winning journalist who writes feature stories for Huntington's Disease News. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
An oral granule formulation of Ingrezza, called Ingrezza Sprinkle, has been granted FDA approval for treating Huntington's-associated chorea.| Huntington's Disease News
Category archive page for News.| Huntington's Disease News
Lindsey Shapiro is a science writer for Huntington's Disease News with a PhD in neuroscience. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Mutant huntingtin protein may drive nerve cell death by poking holes in the membrane that surrounds and protects cells' DNA-filled core.| Huntington's Disease News
Columnist Carlos Briceño's wife, Jill, has always been unstoppable and fiercely independent. One day, Huntington's will change that.| Huntington's Disease News
Researchers suggest people carrying a Huntington's-causing mutation reduce sedentary behavior to delay the occurrence of motor symptoms.| Huntington's Disease News
Columnist Carlos Briceño and his wife with Huntington's, Jill, have a wish list for whoever becomes the new president of the HDSA.| Huntington's Disease News
Education levels, alcohol intake, not smoking, and a good weight before symptoms manifest may affect Huntington's disease progression.| Huntington's Disease News
Levels of GFAP in cerebrospinal fluid (CSF) may be a marker of Huntington’s disease progression, a study found.| Huntington's Disease News
Ingrezza Sprinkle is a formulation of oral Ingrezza that's designed to be easier to swallow, with capsule's granules sprinkled on soft foods.| Huntington's Disease News